Therefore, approaches to enhance EphrinB2 signaling may represent a novel therapeutic avenue for treating myocardial ischemia by enhancing cardiac lymphangiogenesis in acute MI patients. The gene discussed is EFNB2; the disease is myocardial ischemia.